Overview
Hexylresorcinol is a substituted dihydroxybenzene. It exhibits antiseptic, anthelmintic, and local anesthetic properties. It can be found in topical applications for minor skin infections and in oral solutions or throat lozenges for pain relief and first aid antiseptic. The compound may also be used commonly in various commercial cosmetic anti-aging creams while ongoing studies research the possibility of using hexylresorcinol as an anti-cancer therapy - indications all of which require further study and testing at the current moment.
Background
Hexylresorcinol is a substituted dihydroxybenzene. It exhibits antiseptic, anthelmintic, and local anesthetic properties. It can be found in topical applications for minor skin infections and in oral solutions or throat lozenges for pain relief and first aid antiseptic. The compound may also be used commonly in various commercial cosmetic anti-aging creams while ongoing studies research the possibility of using hexylresorcinol as an anti-cancer therapy - indications all of which require further study and testing at the current moment.
Indication
Hexylresorcinol is predominantly employed as the active ingredient in lotions, sprays, or lozenges indicated as a (a) topical antiseptic to help prevent skin infection in minor cuts, scrapes, or burns, or (b) as an antiseptic and local anesthetic for the relief of a sore throat and its associated pain . In addition, hexylresorcinol is used as an active ingredient in various commercial cosmetic skincare products as an anti-aging cream while other studies have looked into whether or not the compound could be used effectively as an anti-inflammatory agent or even as an anti-cancer therapy .
Associated Conditions
- Mouth irritation
- Pain, Orofacial
- Skin Infections
- Sore Throat
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| RB Health (US) LLC | 72854-262 | ORAL | 2 mg in 1 1 | 4/8/2025 | |
| RB Health (US) LLC | 72854-263 | ORAL | 2 mg in 1 1 | 4/8/2025 | |
| RB Health (US) LLC | 72854-261 | ORAL | 2.4 mg in 1 1 | 4/8/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| DEQUASIN EXTRA LOZ - LEMON AND HONEY (HEXYLRESORCINOL & BENZALKONIUM CHLORIDE) | N/A | N/A | N/A | 7/20/2009 | |
| DIFFLAM HEXTRA HEXYLRESORCINOL LOZENGES 2.4MG | N/A | N/A | N/A | 5/23/2022 | |
| DEQUASIN EXTRA LOZ - BLACKBERRY (HEXYLRESORCINOL & BENZALKONIUM CHLORIDE) | N/A | N/A | N/A | 7/20/2009 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| STREPSILS EXTRA hexylresorcinol 2.4 mg honey & lemon flavour lozenge blister pack | 287475 | Medicine | A | 4/4/2017 | |
| ANTICOL MAX NUMBING - Raspberry flavour hexylresorcinol 2.5mg lozenge blister pack | 192715 | Medicine | A | 12/7/2011 | |
| STREPSILS EXTRA hexylresorcinol 2.4 mg blackcurrant flavour lozenge blister pack (reformulation) | 82802 | Medicine | A | 5/23/2002 | |
| STREPSILS EXTRA hexylresorcinol 2.4 mg fresh blackcurrant flavour lozenge blister pack | 360059 | Medicine | A | 4/7/2021 |